STAT — Reporting from the frontiers of health and medicine
- Politics No one has any idea how much money seniors could pay for new Alzheimer’s drug
- Health Tech In a battle over the future of U.S. health care, a question emerges: Is primary care scalable?
- The Readout LOUD Listen: #JPM22 in review, Biogen’s worsening fortunes, & the future of RNA drugs
- Health CDC encourages more Americans to consider N95 masks
- Pharmalot Martin Shkreli is ordered to pay $64 million and is banned from the pharma industry for life
- Politics No one has any idea how much money seniors could pay for new Alzheimer’s drug
- Health Tech In a battle over the future of U.S. health care, a question emerges: Is primary care scalable?
- The Readout LOUD Listen: #JPM22 in review, Biogen’s worsening fortunes, & the future of RNA drugs
- Health CDC encourages more Americans to consider N95 masks
- Pharmalot Martin Shkreli is ordered to pay $64 million and is banned from the pharma industry for life
Exclusive analysis of biotech, pharma, and the life sciences
- Pharmalot At Davos, a ‘good news, bad news’ message emerges about Covid-19
- First Opinion Confessions of a ‘human guinea pig’: Why I’m resigning from Moderna vaccine trials
- In the Lab Strong new evidence suggests a virus triggers multiple sclerosis
-
- Health CDC encourages more Americans to consider N95 masks
- Health The Covid-19 Tracker
- Health Study raises doubts about rapid Covid tests’ reliability in early days after infection
- In the Lab A lucky few seem ‘resistant’ to Covid-19. Scientists want to know why
- Matt's Take The tragedy of Johnson & Johnson’s Covid vaccine
